Delivery Order SPE2DB20D2001-SPE2DB23FM70N
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) with a ceiling value of $45,529.89. The contract is for the supply of 4561307353 - UROXATRAL 10 MG TABLET 100S, a pharmaceutical product, and was awarded by the Defense Logistics Agency (DLA), a defense agency. The award has a completion date of June 21, 2023 and was issued on June 20, 2023. There was no set-aside designation for this contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $11,796.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract has a completion date of February 13, 2024 and is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,025.13, is a delivery order for the supply of 4563551117 UROXATRAL 10 MG TABLET 100S. The contract has a firm fixed price and an ultimate completion date of February 6, 2024. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,361.73 fixed-price delivery order is for the supply of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of...
- This federal contract award, valued at $10,832.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Uroxatral 10 mg tablets. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $79,023.53 firm fixed-price delivery order is for the supply of Uroxatral 10 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award is for the delivery of Uroxatral 10 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price of $8,974.85 and a completion date of February 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,169.94 Firm Fixed Price Delivery Order contract covers the supply of 4562815931 UROXATRAL 10 MG TABLET 100S, a pharmaceutical product, with a period of performance through November 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type. The DO was awarded by the Defense Logistics Agency (DLA) for pharmaceutical products, including Uroxatral 10 mg tablets. The contract has an ultimate completion date of August 25, 2022 and a ceiling value of $83,841.84. This is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,355.89, is for the delivery of Uroxatral 10 mg tablets. It is a firm fixed-price delivery order with a completion date of September 15, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB23FM70NDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $34,316.57 fixed-price delivery order is for the procurement of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of August 29, 2023 and was awarded on August 28, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceuticals and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.3k | 8/28/23 |